Activist 13D/13G Filings - Innoveren Scientific Inc. (IVRN)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-14
12:57 pm
Unchanged		13GINNOVEREN SCIENTIFIC, INC.
IVRN		Lynch Frederick J85,740
4.850%		0
(Unchanged)		View
2024-02-06
4:00 pm
Purchase		13DINNOVEREN SCIENTIFIC, INC.
IVRN		FWHC HOLDINGS LLC697,273
34.380%		697,273increase
(New Position)		View
2023-02-10
5:07 pm
Purchase		13GINNOVEREN SCIENTIFIC, INC.
IVRN		Lynch Frederick J85,740
8.950%		85,740increase
(New Position)		View
2022-02-25
4:05 pm
Purchase		13DINNOVEREN SCIENTIFIC, INC.
IVRN		FWHC HOLDINGS LLC697,263,374
67.740%		42,302,361increase
(+6.46%)		View
2022-02-15
5:37 pm
Purchase		13GINNOVEREN SCIENTIFIC, INC.
IVRN		Lynch Frederick J77,416,438
11.200%		77,416,438increase
(New Position)		View
2021-03-11
06:04 am
Sale		13DINNOVEREN SCIENTIFIC, INC.
IVRN		FWHC HOLDINGS LLC654,961,013
68.700%		-18,559,722decrease
(-2.76%)		View
2020-09-30
8:09 pm
Purchase		13DINNOVEREN SCIENTIFIC, INC.
IVRN		FWHC HOLDINGS LLC673,520,735
69.410%		24,255,288increase
(+3.74%)		View
2020-07-10
4:13 pm
Purchase		13DINNOVEREN SCIENTIFIC, INC.
IVRN		FWHC HOLDINGS LLC649,265,447
69.680%		619,925,933increase
(+2112.94%)		View
2020-05-20
4:40 pm
Unchanged		13DINNOVEREN SCIENTIFIC, INC.
IVRN		FWHC HOLDINGS LLC29,339,514
22.700%		0
(Unchanged)		View
2020-02-25
4:10 pm
Purchase		13DINNOVEREN SCIENTIFIC, INC.
IVRN		FWHC HOLDINGS LLC29,339,514
22.800%		29,339,514increase
(New Position)		View